Leading the Life Sciences Revolution with Jenn Azar, CEO of Stellix
About this episode
This episode features Jenn Azar discussing the impact of AI and digital transformation on life sciences and drug discovery.
In this episode of Building AI Boston, co-hosts Anna Devere and Kara Peterson sit down with Jenn Azar, CEO of Stellix, a visionary leader helping accelerate innovation at the intersection of science, technology, and human ingenuity. They explore how AI, digital transformation, and Industry 5.0 are reshaping the future of life sciences and drug discovery—from advanced manufacturing to personalized medicine—and how leaders can guide teams through change with empathy, humor, and purpose. Highlights: • How Industry 5.0 is bridging discovery and delivery in life sciences • The digital acceleration of drug discovery and biomanufacturing • Building adaptive, curious teams in a rapidly changing world • Why technology should create more space for human creativity • What it takes to lead with optimism and resilience amid transformation AI isn’t just transforming industry—it’s redefining how science moves from the lab to life. 🌐 BuildingAIBoston.com 🎧 Listen on Spotify 🎥 Watch on YouTube 💼 Learn more about Stellix: https://www.stellix.com 👥 Follow co-hosts: Anna Devere | Kara Peterson #BuildingAIBoston, #AI, #Industry5_0, #DigitalTransformation, #LifeSciencesInnovation, #DrugDiscovery…
More episodes of Building AI Boston
- “It’s About Us” with guest Bryan Reimer, Research Scientist at MIT
- The Ethical AI Puzzle with guest Cansu Canca on Building AI Boston
- Reimagining Healthcare in the Age of AI with Sheila Phicil
- The future of workflow with Andie Dovgan
- Accessible by Design with guest Sandy Lacey, Perkins School for the Blind
- AI-Powered Accessibility with Raquel Ronzone, Perkins School for the Blind
Explore listener stats, chart rankings, contacts and more on the Building AI Boston podcast page.